Does TOFACITINIB Cause Blood creatine phosphokinase increased? 125 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Blood creatine phosphokinase increased have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
125
Reports of Blood creatine phosphokinase increased with TOFACITINIB
0.1%
of all TOFACITINIB reports
2
Deaths
27
Hospitalizations
How Dangerous Is Blood creatine phosphokinase increased From TOFACITINIB?
Of the 125 reports, 2 (1.6%) resulted in death, 27 (21.6%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Blood creatine phosphokinase increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 125 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Blood creatine phosphokinase increased?
ATORVASTATIN (1,491)
SIMVASTATIN (895)
ROSUVASTATIN (859)
QUETIAPINE (663)
CLOZAPINE (610)
ARIPIPRAZOLE (594)
OLANZAPINE (561)
DAPTOMYCIN (461)
RISPERIDONE (402)
EZETIMIBE (350)
Which TOFACITINIB Alternatives Have Lower Blood creatine phosphokinase increased Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN